Added 23 days ago Drug news

Positive Phase III results for roxadustat in CKD patients with anemia and not on dialysis.-Astellas

Astellas Pharma Inc. has announced that roxadustat, an inhibitor of hypoxia ¬inducible factor (HIF) prolyl hydroxylase activity, met its primary...

Added 5 months ago Drug news

FDA approves Retacrit for anemia caused by chronic kidney disease or chemotherapy.- Hospira/Pfizer.

The FDA has approved Retacrit (epoetin alfa-epbx) from Hospira/Pfizer, as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of...

Added 9 months ago Drug news

Breakthrough Therapy designation to Promacta for use in the treatment of severe aplastic anemia as a first-line therapy.-Novartis.

Novartis has announced that the FDA has granted Breakthrough Therapy designation to Promacta (eltrombopag) for use in combination with standard...

Benzodiazepine-associated delirium in critically ill adults.

The association between benzodiazepine use and delirium risk in the ICU remains unclear.

Added 1 year ago

Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study.

To ascertain the relationship among early (first 48 h) deep sedation, time to extubation, delirium and long-term mortality.

Added 1 year ago

Early intensive care sedation predicts long-term mortality in ventilated critically ill patients.

Choice and intensity of early (first 48 h) sedation may affect short- and long-term outcome.

Added 1 year ago